Comprehensive In & Out Licensing Advisory

With an active calling effort on more than 300 healthcare companies worldwide, our professionals are a trusted source of new and exciting in-licensing opportunities. Our firm has represented U.S., European and Canadian companies seeking to partner their products in the United States, Europe, Asia and Latin America. We also work with leading U.S. specialty pharmaceutical companies to in-license novel pharmaceutical compounds and cutting-edge medical devices. As product acquisition opportunities have become increasingly competitive, corporate partnering has become more important for driving enterprise value – especially for specialty pharmaceutical companies. Leveraging our extensive relationships, we are able to uncover interesting product opportunities for commercialization throughout the world.

The outward partnering process involves a defined three step process that typically takes 16 to 20 weeks from inception:

Strategy

• Determine Objectives
• Review Regulatory Strategy
• Perform Strategic Assessment of Market/s
• Develop Initial List of Potential Partners by Territory and Therapeutic Priorities
• Build Consensus on Timing and Execution of Plan

Execution

• Prepare Teaser
• Prepare Comprehensive Memorandum
• Identify Partners & Contact Partners
• Prepare and Distribute CDA
• Distribute Information Memorandum
• Solicit Proposals (Term Sheets)
• Evaluate Proposals with Management
• Select Top Proposals

Diligence & Closing

• Negotiate Term Sheet
• Conduct Due Diligence
• Negotiate Licensing Agreement
• Licensor Due Diligence
• On Site Meetings
• Selection of Final Licensor
• Execute Agreement